Skip to main content
Tata Mutual Fund logo

Tata Nifty MidSmall Healthcare Index Fund

Tata Mutual FundDirectOpen-endedIndex FundsRiskometer: Very High Risk

NAV

₹15

as of 6 Oct 2026

Tata Nifty MidSmall Healthcare Index Fund is an open-ended Index Funds scheme from Tata Mutual Fund managing ₹219 crore (as of 31 Aug 2026). Its Direct-plan NAV is ₹15 as of 6 Oct 2026. The expense ratio is 0.59% a year. Managed by Rakesh Prajapati. This page is factual data only – it carries no rating and no recommendation.

Key facts

Expense ratio
0.59% / yr
as of 31 Aug 2026
Fund size
₹219 crore
as of 31 Aug 2026
Exit load
0.25%
SIP available
Yes
Launched
26 Apr 2024
ISIN
INF277KA1BG3

₹100 invested, fund vs category

The category line is the average of the funds in this category, built from nyvo’s own NAV data.

Rebased to 100data to 5 Oct 2026Benchmark: Nifty MidSmall Healthcare

Apr 2024Oct 2026
Growth of ₹100, Tata Nifty MidSmall Healthcare Index Fund versus Index Funds average.

Tata Nifty MidSmall Healthcare Index Fund

₹148

+48% on ₹100 over 2.4 yrs

Index Funds average

₹118

+18% on ₹100 over 2.4 yrs

Returns vs category

WindowFundCategory avgGap
3 months-0.32%-1.84%+1.52
6 months18.00%15.24%+2.76
1 year14.21%13.84%+0.37

No category average is available for this fund. Short windows are noise; the 3 and 5-year rows are the record. Past returns do not predict future returns.

Distance below its own peak

Every dip below 0 is the fund trading under a previous high – how deep and for how long is what a drawdown feels like.

Right now

-5.3% below peak

Apr 2024Deepest: -16.9%Oct 2026

Where the money actually is

Equity

100.1%

Cash

-0.1%

Whole-portfolio split, as of 31 Aug 2026. The size split below covers only the equity slice of this.

What it owns

32 positions · top 10 = 60.0%

Market-cap mix (equity sleeve)

Mid 67.6%Small 32.5%

as of 31 Aug 2026

Holdings by sector

  • Healthcare(10 in top 10)97.7%
    • Laurus Labs Ltd11.22%
    • Lupin Ltd8.01%
    • Aurobindo Pharma Ltd7.16%
    • Fortis Healthcare Ltd7.12%
    • Glenmark Pharmaceuticals Ltd5.62%
    • Alkem Laboratories Ltd4.70%
    • Biocon Ltd4.43%
    • Ipca Laboratories Ltd4.13%
    • Mankind Pharma Ltd4.13%
    • Gland Pharma Ltd3.46%
  • Basic Materials2.5%

Sectors marked ▶ expand to show this fund’s top-10 holdings in that sector. Holdings as of 31 Aug 2026. Portfolio turnover 29.2% vs category 33.7% a year.

Money in, money out

Net flow, 12 months
+₹30 cr
Net flow, 3 months
+₹29 cr

as of 31 Aug 2026. Flows follow performance more than they predict it.

Quick answers

What is the NAV of Tata Nifty MidSmall Healthcare Index Fund?
₹15 per unit as of 6 Oct 2026 (Direct plan, growth). NAV is declared daily on working days.
What is the expense ratio of Tata Nifty MidSmall Healthcare Index Fund?
0.59% a year for the Direct plan, as of 31 Aug 2026.
How large is Tata Nifty MidSmall Healthcare Index Fund?
₹219 crore under management as of 31 Aug 2026, in the Index Funds category.
How risky is Tata Nifty MidSmall Healthcare Index Fund?
Its SEBI Riskometer reading is "Very High Risk". Own the whole market, pay almost nothing. A great deal of the ETF money is EPFO's.
Who manages Tata Nifty MidSmall Healthcare Index Fund?
Rakesh Prajapati, managing this fund for 1.7 years.

Where this fund sits

Other Index Funds funds

Data: nyvo research systems; each block above states its own as-of date, and blocks with no data for this fund are omitted rather than estimated. NAV updates daily on working days. The benchmark (Nifty MidSmall Healthcare) is named for reference only; its values are licensed and never shown. This page is factual information about one scheme. It is not investment advice, not a recommendation, and it carries no rating of any kind. Past performance does not predict future returns. Mutual fund investments are subject to market risks; read all scheme related documents carefully.